Shilanski & Associates’s Accenture ACN Stock Holding History

Shilanski & Associates’s Portfolio ACN Stock Details ACN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-7,911	Closed	-$2.04M	–	115
2022 Q3	$2.04M	Buy	+7,911	New	+$2.29M	0.75%	26

Other funds holding ACN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AWA

Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Shilanski & Associates's ACN Position: Q4 2022 in Review

Shilanski & Associates sold out of Accenture (ACN) in Q4 2022, closing a stake of 7,911 shares — an estimated $2.04M sold.

Shilanski & Associates first reported a position in ACN in Q3 2022 and held it in 1 quarter. The position peaked at $2.04M in Q3 2022. 2,042 funds tracked by Wall St. Rank hold ACN as of Q4 2022.

Shilanski & Associates reported no remaining Accenture position as of Q4 2022 after selling out during the quarter.
Shilanski & Associates sold 7,911 Accenture shares in Q4 2022, an estimated $2.04M.
Shilanski & Associates first reported a position in Accenture in Q3 2022 and held it in 1 quarter.
Shilanski & Associates's Accenture position peaked at $2.04M in Q3 2022.
2,042 funds tracked by Wall St. Rank held Accenture as of Q4 2022.

Based on Shilanski & Associates's 13F filing for Q4 2022, filed 31 Jan 2023.